Shanghai Hutchison Pharmaceuticals Limited Report issue

For profit Phase 2 Phase 4
Founded: Shanghai China (1958)
Status: No NME R&D (1958)

Organization Overview

First Clinical Trial
2011
NCT01897805
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company Limited | Shanghai Hutchison Pharmaceuticals Limited

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Coronary Artery Disease (Phase 4)

Coronary Disease (Phase 4)

Dementia (Phase 2)

Dementia, Vascular (Phase 2)

Influenza, Human (Phase 4)

Myocardial Ischemia (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 9